Fri, Jul 25, 2014, 5:37 AM EDT - U.S. Markets open in 3 hrs 53 mins


% | $
Click the to save as a favorite.

Thoratec Corp. Message Board

  • professor4everyone professor4everyone Feb 5, 2013 6:27 PM Flag

    In Conclusion The H/MVAD 160mg To 325 mg Aspirin Dose Is Still A device-killer

    The Simple HM3 MagLev technology is far superior to the H/MVAD overly complex blood-flow technology and allows much further efficacy and cost reduction.

    The FILVAS fully implantable technology is having great success in testing and should eliminate Heart Transplants. The Bionic Man has arrived.

    THOR will fully dominate the HUGE multi-BILLION$$$ Heart Failure market in both implants and in the Acute Catheter Lab.

    Meanwhile THOR's Free-Cash-Flow is outstanding and will continue to sharply reduce share count with continuous buy-backs. And they have ZERO DEBT!!!!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
32.55-0.13(-0.40%)Jul 24 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.